Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers
Nathan Koch, Olivier Jennotte, Youri Gasparrini, et al.
International Journal of Pharmaceutics (2020) Vol. 589, pp. 119812-119812
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
H.M.S. Al Ubeed, Deep Jyoti Bhuyan, Muhammad A. Alsherbiny, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 604-604
Open Access | Times Cited: 85
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 99
Preparation, stability, antioxidative property and in vitro release of cannabidiol (CBD) in zein-whey protein composite nanoparticles
Ce Wang, Baihui Cui, Yonghai Sun, et al.
LWT (2022) Vol. 162, pp. 113466-113466
Open Access | Times Cited: 44
The Transdermal Delivery of Therapeutic Cannabinoids
Haleh Mahmoudinoodezh, Srinivasa Reddy Telukutla, Sukhvir Kaur Bhangu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 40
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon C. Arnold, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1087-1114
Open Access | Times Cited: 27
Variable pore size of mesoporous silica in improving physical stability and oral bioavailability of insoluble drugs
Wanhao Qi, Jinghao Chen, Shiqiao Rui, et al.
International Journal of Pharmaceutics (2025), pp. 125394-125394
Closed Access | Times Cited: 1
Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery
Giulia Vanti, Lucia Grifoni, Maria Camilla Bergonzi, et al.
International Journal of Pharmaceutics (2021) Vol. 607, pp. 121036-121036
Closed Access | Times Cited: 44
Cannabidiol and terpenes from hemp – ingredients for future foods and processing technologies
Chang Chen, Zhongli Pan
Journal of Future Foods (2021) Vol. 1, Iss. 2, pp. 113-127
Open Access | Times Cited: 44
Extraction of Bioactive Compounds From Cannabis sativa L. Flowers and/or Leaves Using Deep Eutectic Solvents
Francisco J. Tiago, Alexandre Paiva, Ana A. Matias, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 28
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol
Lie Yun Kok, Pauric Bannigan, Forugh Sanaee, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 168, pp. 106058-106058
Open Access | Times Cited: 40
Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations
Maria Lapteva, Jonathan Faro Barros, Yogeshvar N. Kalia
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 202-202
Open Access | Times Cited: 5
Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability
Nathan Koch, Quentin Bourcy, Olivier Jennotte, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 79-79
Open Access
O-carboxymethyl chitosan-grafted-cholesterol succinic acid monoester nanomicelles improve oral absorption of cannabidiol: Preparation, intestinal absorption in vitro, and pharmacokinetics in vivo
Rui Li, Wenhui Ruan, Rui Hao, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106763-106763
Closed Access
Towards Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding
A. Cherif, Jayavant Trimbak Deshmukh, Kavish Sanil, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Open Access
High-Pressure Dielectric Spectroscopic Studies of Amorphous CBD: Investigating Molecular Dynamics and Physical Stability Under Manufacturing Conditions of the Pharmaceuticals
Mariya Mathew, Justyna Knapik-Kowalczuk, Mateusz Dulski, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 358-358
Open Access
In Vitro Release, Mucosal Permeation and Deposition of Cannabidiol from Liquisolid Systems: The Influence of Liquid Vehicles
Peera Tabboon, Thaned Pongjanyakul, Ekapol Limpongsa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1787-1787
Open Access | Times Cited: 22
Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats
Oluwaseyi Salau, Arvind Bagde, Anil Kumar Kalvala, et al.
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122016-122016
Open Access | Times Cited: 20
Oral delivery of cannabidiol: Revealing the formulation and absorption challenges
Andrejs Šitovs, Konstantīns Logviss, Līga Lauberte, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105316-105316
Closed Access | Times Cited: 12
Structural Investigation of Beta-Cyclodextrin Complexes with Cannabidiol and Delta-9-Tetrahydrocannabinol in 1:1 and 2:1 Host-Guest Stoichiometry: Molecular Docking and Density Functional Calculations
Nat Triamchaisri, Pisanu Toochinda, Luckhana Lawtrakul
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1525-1525
Open Access | Times Cited: 11
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
Sumit Bansal, Mayur K. Ladumor, Mary F. Paine, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 6, pp. 743-752
Closed Access | Times Cited: 11
Continuous Manufacturing of Solvent-Free Cyclodextrin Inclusion Complexes for Enhanced Drug Solubility via Hot-Melt Extrusion: A Quality by Design Approach
Siva Ram Munnangi, Ahmed Adel Ali Youssef, Nagarjuna Narala, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2203-2203
Open Access | Times Cited: 11
Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
Zonghao Hu, Zishun Qin, Jinhong Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116271-116271
Open Access | Times Cited: 4
Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder
Bruno Gomes, Laure-Anne Bya, Nathan Koch, et al.
The AAPS Journal (2025) Vol. 27, Iss. 1
Closed Access
Effect of Different Extraction Methods on the Structural Analysis, Water Solubility, and Bioactivity of Hemp Polysaccharides-Cannabidiol Complexes
Hang Li, Bowen Li, Yuan Zhu, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2025), pp. 136729-136729
Closed Access
A critical review on thermodynamic and hydrodynamic modeling and simulation of liquid antisolvent crystallization of pharmaceutical compounds
Amit K. Thakur, Rahul Kumar, Vipin Kumar, et al.
Journal of Molecular Liquids (2022) Vol. 362, pp. 119663-119663
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top